check_circleStudy Completed

Hypertension

Bayer Identifier:

13599

ClinicalTrials.gov Identifier:

NCT00927537

EudraCT Number:

Not Available

EU CT Number:

Not Available
Therapy of Essential Hypertension With Kinzal®/ Kinzalplus®

Trial purpose

The efficacy and tolerability of an antihypertensive treatment with Telmisartan is followed over 3-4 months

Key Participants Requirements

Sex

Both

Age

18 - N/A

  • - Hypertensive patients seen by the physician requiring antihypertensive treatment

  • - According to the local drug information

Trial summary

Enrollment Goal
2052
Trial Dates
April 2008 - October 2011
Phase
N/A
Could I Receive a placebo
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, Switzerland

Primary Outcome

  • Blood pressure
    date_rangeTime Frame:
    After 1-2 weeks, 1month, 3-4 months
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Change in Mean heart rate (bpm)
    date_rangeTime Frame:
    Baseline and 3-4 month
    enhanced_encryption
    Safety Issue:
    No
  • Change in Mean Weight (kg)
    date_rangeTime Frame:
    Baseline and 3-4 month
    enhanced_encryption
    Safety Issue:
    No
  • Change in Mean laboratory parameters (total cholesterol, LDL, HDL, triglyceride, fasting blood glucose)
    date_rangeTime Frame:
    Baseline and 3-4 month
    enhanced_encryption
    Safety Issue:
    No
  • Patient Medical History: Duration of hypertension, Pre-treatment of hypertension, Comorbidities and Concomitant treatment
    date_rangeTime Frame:
    Baseline
    enhanced_encryption
    Safety Issue:
    No
  • Final evaluation of efficacy (very good, good, sufficient, insufficient) and tolerability (very good, good, sufficient, insufficient) of treatment by the physician.
    date_rangeTime Frame:
    After 3-4 month
    enhanced_encryption
    Safety Issue:
    No

Trial design

Data collection on hypertension and its treatment with Kinzal®/ Kinzalplus®
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to Bayer Healthcare products.